Affan Zafar, M.D.

Urology
Bladder Cancer
Prostate Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8765

Biography

Affan Zafar, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. He specializes in genitourinary cancers including prostate, kidney, bladder, and testicular cancer.

Dr. Zafar earned his medical degree at Baylor College of Medicine. He completed a residency in urologic surgery at Washington University’s Barnes-Jewish Hospital and received advanced fellowship training in urologic oncology at Harvard Medical School. He joined the UT Southwestern faculty in 2023.

Dr. Zafar is a member of the American Urological Association and the Society of Urologic Oncology.

He has delivered presentations at national meetings and published peer-reviewed academic articles on bladder cancer and bladder preservation treatments.

Personal Note

When he’s not at work, Dr. Zafar enjoys spending time with his wife and two children, traveling, hiking, and reading.

Education & Training

Medical Education - Baylor College of Medicine (2012-2016)
Internship - Washington University School of Medicine (2016-2017), General Surgery
Residency - Washington University Barnes Jewish Hospital Center (2017-2021), Urology
Fellowship - Harvard Medical School (2021-2023)

Professional Associations & Affiliations

American Urological Association
Society of Urologic Oncology

Books & Publications

Books
- Management of infertility in Klinefelter Syndrome in Male Infertility: A Clinical Approach
  Ramasamy R, Zafar A (2017), New York, Springer
Publications
- Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.
  Khene ZE, Bhanvadia R, Tachibana I, Issa W, Graber W, Trevino I, Woldu SL, Gaston K, Zafar A, Hammers H, Cole S, Zhang T, Bensalah K, Lotan Y, Margulis V, Clinical genitourinary cancer 2025 Jan 23 2 102307
- Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis.
  Hinojosa-Gonzalez DE, Zafar A, Saffati G, Kronstedt S, Zlatev DV, Khera M, Prostate cancer and prostatic diseases 2024 Jan
- Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
  Yim K, Melnick K, Mott SL, Carvalho FLF, Zafar A, Clinton TN, Mossanen M, Steele GS, Hirsch M, Rizzo N, Wu CL, Mouw KW, Wszolek M, Salari K, Feldman A, Kibel AS, O'Donnell MA, Preston MA, Urologic oncology 2023 Sep
- Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.
  Weinberg MS, Zafar A, Magdamo C, Chung SY, Chou WH, Nayan M, Deodhar M, Frendl DM, Feldman AS, Faustman DL, Arnold SE, Vakulenko-Lagun B, Das S, JAMA network open 2023 May 6 5 e2314336
- Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.
  Stavrou E, Qiu J, Zafar A, Tramontano AC, Isakoff S, Winer E, Schrag D, Manz C, JCO oncology practice 2022 Sep 18 9 e1447-e1453
- Dual-frequency setting for urinary stone fragmentation during shock wave lithotripsy: an in vitro study.
  Han CS, Vetter JM, Endicott R, Chevinsky M, Zafar A, Venkatesh R, Urolithiasis 2020 Aug 48 4 369-375

Research

Improving surveillance for prostate and bladder cancer
Improving bladder preservation treatments for bladder cancer

Clinical Focus

Bladder Cancer
Prostate Cancer
Kidney Cancer
Testicular Cancer
Robotic Surgery